Sequential administration of OKT3 (anti-CD3) and interleukin-2 in two patients with chemoresistant hematological disease

Eur J Haematol. 1992 Sep;49(3):150-2. doi: 10.1111/j.1600-0609.1992.tb00922.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Drug Administration Schedule
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Hematologic Diseases / drug therapy*
  • Hematologic Diseases / physiopathology
  • Humans
  • Interleukin-2 / therapeutic use*
  • Muromonab-CD3 / therapeutic use*

Substances

  • Interleukin-2
  • Muromonab-CD3